- £210.67m
- £116.46m
- $84.80m
- 22
- 47
- 51
- 30
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 377 | 160 | 335 | 402 | 84.8 |
Cost of Revenue | |||||
Gross Profit | 182 | -26.3 | 116 | 233 | 19.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 245 | 524 | 612 | 255 | 104 |
Operating Profit | 132 | -365 | -277 | 147 | -19.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 105 | -417 | -308 | 122 | -28.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 104 | -417 | -308 | 122 | -28.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 104 | -417 | -308 | -7.3 | -61.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 104 | -417 | -308 | -7.3 | -61.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.475 | -0.842 | -0.166 | 0.722 | -0.074 |
Dividends per Share |